{"id":"jueling-mingmu-decoction","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This herbal decoction operates within the framework of Traditional Chinese Medicine theory, targeting the liver and kidney meridians which are believed to govern eye function and vision. The combination of herbs in the formula aims to improve blood circulation to the eyes, reduce inflammation, and restore balance to support visual acuity and ocular health.","oneSentence":"Jueling Mingmu decoction is a traditional Chinese medicine formulation designed to improve vision and eye health by nourishing the liver and kidney systems.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:36:47.975Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Vision improvement and eye health support"}]},"trialDetails":[{"nctId":"NCT06234514","phase":"PHASE4","title":"Manage Macular Cystoid Edema With Retinal Vein Obstruction Using Traditional Chinese Medicine and Ranibizumab","status":"COMPLETED","sponsor":"Dongyang People's Hospital","startDate":"2023-01-01","conditions":"Macular Cystoid Edema","enrollment":111}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Jueling Mingmu decoction","genericName":"Jueling Mingmu decoction","companyName":"Dongyang People's Hospital","companyId":"dongyang-people-s-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Jueling Mingmu decoction is being studied in a clinical trial as a treatment for Macular Cystoid Edema associated with retinal vein obstruction. The trial is comparing the efficacy of Jueling Mingmu decoction to intravitreal injections of 0.5mg ranibizumab in managing Macular Cystoid Edema.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}